UNSPSC 51341901: Zanamivir

This classification denotes an antiviral agent with the molecular formula C12H20N4O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L6O3XI777I, chemically known as 5-acetamido-4-guanidino-6-(1,2,3-trihydroxypropyl)-5,6-dihydro-4h-pyran-2-carboxylic acid but generally known as zanamivir, which bears US NIH Compound Identifier 60855. European Medicines Agency schedules Zanamivir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00137MIG.

UNSPSC 51341901 Zanamivir, a Commodity code, nominally designates an individual antiviral pharmaceutical product, yet recent state and local solicitations tagged under this code reveal a much broader procurement pattern: state and local agencies are buying generic pharmaceuticals, over-the-counter products, emergency medical supplies, and naloxone through cooperative purchasing vehicles and direct competitive bids. The work encompasses manufacturer relationships, wholesaler-mediated distribution networks, first-responder medical consumables, and state pharmacy benefit program initiatives. Issuing bodies span state health agencies (Texas Health and Human Services Commission), county public health authorities (Seminole County, Florida), municipal fire and rescue departments (City of Tampa Fire Department), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local government facilities across participating jurisdictions). The code's scope in active procurements diverges significantly from its nominal definition, signaling that state and local procurement offices are using it as a catchall for pharmaceutical and medical-supply categories rather than zanamivir specifically.

Recent activity clusters in Florida, Minnesota, Texas, and Oregon. Representative opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building; the City of Tampa's IFB 26P00145 (due March 13, 2026) for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, a $700,000 estimated contract sheltered for certified Small Local Business Enterprises with a 5 percent bid discount; the Texas Health and Human Services Commission's RFI HHS0017013 (due April 3, 2026) exploring direct-to-manufacturer pharmacy prescription programs; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers, effective July 1, 2026, with evaluations weighted 75 percent on price competitiveness. State and local governments are moving toward consolidated pharmaceutical procurement through cooperative vehicles and direct manufacturer relationships to improve cost management and supply chain efficiency.